Listed

Estrella Immunopharma, Inc.

ESLANasdaqCIK 1844417HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$2.1m, Q2 FY2026
Net income−$2.3m, Q2 FY2026
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q4 FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$k483Research and development, Q1 FY2024, three months to 2023-09-30$483.5k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001213900-24-098450.Report this figure75.5Research and development, Q2 FY2024, three months to 2023-12-31$75.5k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-02-14, accession 0001213900-24-014191.Report this figure25.0Research and development, Q3 FY2024, three months to 2024-03-31$25.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001213900-25-043365.Report this figure3,525Research and development, Q4 FY2024, three months to 2024-06-30$3.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001213900-25-074567.Report this figure2,826Research and development, Q1 FY2025, three months to 2024-09-30$2.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figure32.6Research and development, Q2 FY2025, three months to 2024-12-31$32.6k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-18, accession 0001213900-26-029357. Derived: 6-month figure less the 3-month figure.Report this figure1,410Research and development, Q1 FY2025, three months to 2025-03-31$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-18, accession 0001213900-26-058063.Report this figure4,660Research and development, Q2 FY2025, three months to 2025-06-30$4.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure4,153Research and development, Q3 FY2025, three months to 2025-09-30$4.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figure25.4Research and development, Q4 FY2025, three months to 2025-12-31$25.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-18, accession 0001213900-26-029357. Derived: 12-month figure less the 9-month figure.Report this figure1,400Research and development, Q1 FY2026, three months to 2026-03-31$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-18, accession 0001213900-26-058063.Report this figure1,400Research and development, Q2 FY2026, three months to 2026-06-30$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure
Operating income$k(1,870)Operating income, Q1 FY2024, three months to 2023-09-30−$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001213900-24-098450.Report this figure(1,021)Operating income, Q2 FY2024, three months to 2023-12-31−$1.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-02-14, accession 0001213900-24-014191.Report this figure(470)Operating income, Q3 FY2024, three months to 2024-03-31−$469.5k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001213900-25-043365.Report this figure(3,949)Operating income, Q4 FY2024, three months to 2024-06-30−$3.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001213900-25-074567.Report this figure(3,377)Operating income, Q1 FY2025, three months to 2024-09-30−$3.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figure(1,050)Operating income, Q2 FY2025, three months to 2024-12-31−$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-18, accession 0001213900-26-029357. Derived: 6-month figure less the 3-month figure.Report this figure(2,104)Operating income, Q1 FY2025, three months to 2025-03-31−$2.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-18, accession 0001213900-26-058063.Report this figure(5,544)Operating income, Q2 FY2025, three months to 2025-06-30−$5.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure(4,801)Operating income, Q3 FY2025, three months to 2025-09-30−$4.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figure(613)Operating income, Q4 FY2025, three months to 2025-12-31−$613.2k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-18, accession 0001213900-26-029357. Derived: 12-month figure less the 9-month figure.Report this figure(2,292)Operating income, Q1 FY2026, three months to 2026-03-31−$2.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-18, accession 0001213900-26-058063.Report this figure(2,084)Operating income, Q2 FY2026, three months to 2026-06-30−$2.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure
Income tax$knot reportednot reportednot reported1.6Income tax, Q4 FY2024, three months to 2024-06-30$1.6k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0001213900-25-074567.Report this figure0.0Income tax, Q3 FY2025, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001213900-25-109198. Derived: 9-month figure less the 6-month figure.Report this figure0.1Income tax, Q2 FY2025, three months to 2024-12-31$63. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-18, accession 0001213900-26-029357. Derived: 6-month figure less the 3-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$13. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-18, accession 0001213900-26-058063.Report this figure0.9Income tax, Q2 FY2025, three months to 2025-06-30$850. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001213900-25-109198. Derived: 9-month figure less the 6-month figure.Report this figure(0.0)Income tax, Q4 FY2025, three months to 2025-12-31−$25. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-18, accession 0001213900-26-029357. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Net income$k(1,870)Net income, Q1 FY2024, three months to 2023-09-30−$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001213900-24-098450.Report this figure(1,021)Net income, Q2 FY2024, three months to 2023-12-31−$1.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-05-15, accession 0001213900-24-043126.Report this figure(470)Net income, Q3 FY2024, three months to 2024-03-31−$469.5k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figure(3,951)Net income, Q4 FY2024, three months to 2024-06-30−$4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figure(3,377)Net income, Q1 FY2025, three months to 2024-09-30−$3.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figure(1,050)Net income, Q2 FY2025, three months to 2024-12-31−$1.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-18, accession 0001213900-26-029357. Derived: 6-month figure less the 3-month figure.Report this figure(2,104)Net income, Q1 FY2025, three months to 2025-03-31−$2.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure(5,545)Net income, Q2 FY2025, three months to 2025-06-30−$5.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure(4,801)Net income, Q3 FY2025, three months to 2025-09-30−$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figure(613)Net income, Q4 FY2025, three months to 2025-12-31−$613.2k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-18, accession 0001213900-26-029357. Derived: 12-month figure less the 9-month figure.Report this figure(2,292)Net income, Q1 FY2026, three months to 2026-03-31−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure(2,306)Net income, Q2 FY2026, three months to 2026-06-30−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure
Diluted EPS$ per share(1.78)Diluted EPS, Q1 FY2024, three months to 2023-09-30−$1.78 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001213900-24-098450.Report this figure(0.03)Diluted EPS, Q2 FY2024, three months to 2023-12-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-02-14, accession 0001213900-24-014191.Report this figure(0.01)Diluted EPS, Q3 FY2024, three months to 2024-03-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001213900-25-043365.Report this figure(0.11)Diluted EPS, Q4 FY2024, three months to 2024-06-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001213900-25-074567.Report this figure(0.09)Diluted EPS, Q1 FY2025, three months to 2024-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figurenot reported(0.06)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-18, accession 0001213900-26-058063.Report this figure(0.15)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure(0.13)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figurenot reported(0.05)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-18, accession 0001213900-26-058063.Report this figure(0.05)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure
Basic EPS$ per share(1.78)Basic EPS, Q1 FY2024, three months to 2023-09-30−$1.78 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001213900-24-098450.Report this figure(0.03)Basic EPS, Q2 FY2024, three months to 2023-12-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-02-14, accession 0001213900-24-014191.Report this figure(0.01)Basic EPS, Q3 FY2024, three months to 2024-03-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001213900-25-043365.Report this figure(0.11)Basic EPS, Q4 FY2024, three months to 2024-06-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001213900-25-074567.Report this figure(0.09)Basic EPS, Q1 FY2025, three months to 2024-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figurenot reported(0.06)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-18, accession 0001213900-26-058063.Report this figure(0.15)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure(0.13)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figurenot reported(0.05)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-18, accession 0001213900-26-058063.Report this figure(0.05)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure

Balance sheet

Cash and equivalents$100.0k, Q2 FY2026
Shareholders' equity−$7.4m, Q2 FY2026
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31FY20242024-06-30Q1 FY20252024-09-30FY20252024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m22.1Cash and equivalents, Q1 FY2024, at 2023-09-30$22.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-20, accession 0001213900-23-088827.Report this figure9.0Cash and equivalents, Q2 FY2024, at 2023-12-31$9.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-02-14, accession 0001213900-24-014191.Report this figure4.7Cash and equivalents, Q3 FY2024, at 2024-03-31$4.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-15, accession 0001213900-24-043126.Report this figure4.2Cash and equivalents, FY2024, at 2024-06-30$4.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-KT filed 2025-03-25, accession 0001013762-25-002190.Report this figure1.8Cash and equivalents, Q1 FY2025, at 2024-09-30$1.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001213900-24-098450.Report this figure0.9Cash and equivalents, FY2025, at 2024-12-31$916.9k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-18, accession 0001213900-26-029357.Report this figure0.4Cash and equivalents, Q1 FY2025, at 2025-03-31$421.5k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001213900-25-043365.Report this figure1.3Cash and equivalents, Q2 FY2025, at 2025-06-30$1.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001213900-25-074567.Report this figure1.6Cash and equivalents, Q3 FY2025, at 2025-09-30$1.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figure1.4Cash and equivalents, FY2025, at 2025-12-31$1.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-18, accession 0001213900-26-029357.Report this figurenot reported0.1Cash and equivalents, Q2 FY2026, at 2026-06-30$100.0k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure
Current assets$mnot reported9.4Current assets, Q2 FY2024, at 2023-12-31$9.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-02-14, accession 0001213900-24-014191.Report this figure8.6Current assets, Q3 FY2024, at 2024-03-31$8.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001213900-24-043126.Report this figure4.5Current assets, FY2024, at 2024-06-30$4.5m. XBRL concept us-gaap:AssetsCurrent. 10-KT filed 2025-03-25, accession 0001013762-25-002190.Report this figure2.2Current assets, Q1 FY2025, at 2024-09-30$2.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001213900-24-098450.Report this figure1.6Current assets, FY2025, at 2024-12-31$1.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-18, accession 0001213900-26-029357.Report this figure0.9Current assets, Q1 FY2025, at 2025-03-31$944.3k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001213900-25-043365.Report this figure1.5Current assets, Q2 FY2025, at 2025-06-30$1.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001213900-25-074567.Report this figure2.0Current assets, Q3 FY2025, at 2025-09-30$2.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figure1.7Current assets, FY2025, at 2025-12-31$1.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure2.2Current assets, Q1 FY2026, at 2026-03-31$2.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-18, accession 0001213900-26-058063.Report this figure1.8Current assets, Q2 FY2026, at 2026-06-30$1.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure
Total assets$m27.3Total assets, Q1 FY2024, at 2023-09-30$27.3m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-20, accession 0001213900-23-088827.Report this figure9.4Total assets, Q2 FY2024, at 2023-12-31$9.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-02-14, accession 0001213900-24-014191.Report this figure8.6Total assets, Q3 FY2024, at 2024-03-31$8.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001213900-24-043126.Report this figure4.5Total assets, FY2024, at 2024-06-30$4.5m. XBRL concept us-gaap:Assets. 10-KT filed 2025-03-25, accession 0001013762-25-002190.Report this figure3.7Total assets, Q1 FY2025, at 2024-09-30$3.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001213900-24-098450.Report this figure3.1Total assets, FY2025, at 2024-12-31$3.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-18, accession 0001213900-26-029357.Report this figure2.4Total assets, Q1 FY2025, at 2025-03-31$2.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001213900-25-043365.Report this figure3.0Total assets, Q2 FY2025, at 2025-06-30$3.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001213900-25-074567.Report this figure3.5Total assets, Q3 FY2025, at 2025-09-30$3.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figure3.2Total assets, FY2025, at 2025-12-31$3.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure3.7Total assets, Q1 FY2026, at 2026-03-31$3.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-18, accession 0001213900-26-058063.Report this figure1.8Total assets, Q2 FY2026, at 2026-06-30$1.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure
Current liabilities$m17.3Current liabilities, Q1 FY2024, at 2023-09-30$17.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-20, accession 0001213900-23-088827.Report this figure0.4Current liabilities, Q2 FY2024, at 2023-12-31$398.7k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-02-14, accession 0001213900-24-014191.Report this figure0.1Current liabilities, Q3 FY2024, at 2024-03-31$138.5k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001213900-24-043126.Report this figure0.2Current liabilities, FY2024, at 2024-06-30$180.7k. XBRL concept us-gaap:LiabilitiesCurrent. 10-KT filed 2025-03-25, accession 0001013762-25-002190.Report this figure3.0Current liabilities, Q1 FY2025, at 2024-09-30$3.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001213900-24-098450.Report this figure3.0Current liabilities, FY2025, at 2024-12-31$3.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-18, accession 0001213900-26-029357.Report this figure4.3Current liabilities, Q1 FY2025, at 2025-03-31$4.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001213900-25-043365.Report this figure9.1Current liabilities, Q2 FY2025, at 2025-06-30$9.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001213900-25-074567.Report this figure13.4Current liabilities, Q3 FY2025, at 2025-09-30$13.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figure13.5Current liabilities, FY2025, at 2025-12-31$13.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure8.9Current liabilities, Q1 FY2026, at 2026-03-31$8.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-18, accession 0001213900-26-058063.Report this figure9.3Current liabilities, Q2 FY2026, at 2026-06-30$9.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure
Total liabilities$m17.3Total liabilities, Q1 FY2024, at 2023-09-30$17.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-20, accession 0001213900-23-088827.Report this figure0.4Total liabilities, Q2 FY2024, at 2023-12-31$398.7k. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-02-14, accession 0001213900-24-014191.Report this figure0.1Total liabilities, Q3 FY2024, at 2024-03-31$138.5k. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0001213900-24-043126.Report this figure0.2Total liabilities, FY2024, at 2024-06-30$180.7k. XBRL concept us-gaap:Liabilities. 10-KT filed 2025-03-25, accession 0001013762-25-002190.Report this figure3.0Total liabilities, Q1 FY2025, at 2024-09-30$3.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001213900-24-098450.Report this figure3.0Total liabilities, FY2025, at 2024-12-31$3.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-18, accession 0001213900-26-029357.Report this figure4.3Total liabilities, Q1 FY2025, at 2025-03-31$4.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001213900-25-043365.Report this figure9.1Total liabilities, Q2 FY2025, at 2025-06-30$9.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001213900-25-074567.Report this figure13.4Total liabilities, Q3 FY2025, at 2025-09-30$13.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figure13.5Total liabilities, FY2025, at 2025-12-31$13.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure8.9Total liabilities, Q1 FY2026, at 2026-03-31$8.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-18, accession 0001213900-26-058063.Report this figure9.3Total liabilities, Q2 FY2026, at 2026-06-30$9.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure
Shareholders' equity$m10.1Shareholders' equity, Q1 FY2024, at 2023-09-30$10.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0001213900-24-098450.Report this figure9.0Shareholders' equity, Q2 FY2024, at 2023-12-31$9.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figure8.5Shareholders' equity, Q3 FY2024, at 2024-03-31$8.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figure4.3Shareholders' equity, FY2024, at 2024-06-30$4.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-18, accession 0001213900-26-029357.Report this figure0.7Shareholders' equity, Q1 FY2025, at 2024-09-30$746.3k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figure0.1Shareholders' equity, FY2025, at 2024-12-31$143.7k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure(1.8)Shareholders' equity, Q1 FY2025, at 2025-03-31−$1.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure(6.1)Shareholders' equity, Q2 FY2025, at 2025-06-30−$6.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure(9.8)Shareholders' equity, Q3 FY2025, at 2025-09-30−$9.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figure(10.4)Shareholders' equity, FY2025, at 2025-12-31−$10.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure(5.3)Shareholders' equity, Q1 FY2026, at 2026-03-31−$5.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure(7.4)Shareholders' equity, Q2 FY2026, at 2026-06-30−$7.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure

Cash flow

Operating cash flow−$1.8m, Q2 FY2026
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q4 FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(0.3)Operating cash flow, Q1 FY2024, three months to 2023-09-30−$275.2k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001213900-24-098450.Report this figure(11.3)Operating cash flow, Q2 FY2024, three months to 2023-12-31−$11.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-02-14, accession 0001213900-24-014191. Derived: 6-month figure less the 3-month figure.Report this figure(4.2)Operating cash flow, Q3 FY2024, three months to 2024-03-31−$4.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001213900-25-043365.Report this figure(0.3)Operating cash flow, Q4 FY2024, three months to 2024-06-30−$291.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-KT filed 2025-03-25, accession 0001013762-25-002190. Derived: 12-month figure less the 9-month figure.Report this figure(2.2)Operating cash flow, Q1 FY2025, three months to 2024-09-30−$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001213900-24-098450.Report this figure(0.9)Operating cash flow, Q2 FY2025, three months to 2024-12-31−$896.1k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-18, accession 0001213900-26-029357. Derived: 6-month figure less the 3-month figure.Report this figure(0.5)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$466.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-18, accession 0001213900-26-058063.Report this figure(0.4)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$414.9k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001213900-26-089215. Derived: 6-month figure less the 3-month figure.Report this figure(0.7)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$727.3k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001213900-25-109198. Derived: 9-month figure less the 6-month figure.Report this figure(0.2)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$177.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-18, accession 0001213900-26-029357. Derived: 12-month figure less the 9-month figure.Report this figure(6.7)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$6.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-18, accession 0001213900-26-058063.Report this figure(1.8)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001213900-26-089215. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)43.00m, Q2 FY2026
Line itemUnitQ4 FY20222022-12-31period not labelled2023-03-31Q1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q4 FY20242024-06-30Q1 FY20252024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares0.2Diluted shares (weighted), Q4 FY2022, three months to 2022-12-31168,758 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-02-14, accession 0001213900-24-014191.Report this figure0.3Diluted shares (weighted), period not labelled, three months to 2023-03-31337,275 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0001213900-24-043126.Report this figure1.1Diluted shares (weighted), Q1 FY2024, three months to 2023-09-301,052,656 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001213900-24-098450.Report this figure35.2Diluted shares (weighted), Q2 FY2024, three months to 2023-12-3135,201,232 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-02-14, accession 0001213900-24-014191.Report this figure35.5Diluted shares (weighted), Q3 FY2024, three months to 2024-03-3135,519,192 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0001213900-25-043365.Report this figure36.4Diluted shares (weighted), Q4 FY2024, three months to 2024-06-3036,376,738 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001213900-25-074567.Report this figure36.2Diluted shares (weighted), Q1 FY2025, three months to 2024-09-3036,208,477 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figure36.2Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3136,188,293 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-18, accession 0001213900-26-058063.Report this figure36.2Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3036,165,589 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure37.1Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3037,096,024 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001213900-25-109198.Report this figure42.1Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3142,121,075 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-18, accession 0001213900-26-058063.Report this figure43.0Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3042,997,733 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure

Shares outstanding: 43.50mShares outstanding, period not labelled, at 2026-08-1143,497,864 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001213900-26-089215.Report this figure at Aug 11, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.